chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache Injection site pain/discomfort Employee reports injection site pain/discomfort x 3 days and headaches x 3 days following administration of vaccine. Reports all symptoms have resolved as of date of report. Reports too Tylenol every 6 hours by mouth for 3 days.
This case was reported by a pharmacist via call center representative and described the occurrence of sickness in a 79-year-old female patient who received Seasonal Influenza vaccine. On an unknown date, the patient received Seasonal Influenza vaccine at an unknown dose. On an unknown date, an unknown time after receiving Seasonal Influenza vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to Seasonal Influenza vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient received Flu vaccine many years ago. The reporter stated that, the patient was very sick after receiving Flu vaccine. It was reported that, the patient did not elaborate past her being very sick. The reporter did not know the brand of flu vaccine involved.
Hurt arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurt arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer (Cancer Remission .).    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Hurt arm). At the time of the report, PAIN IN EXTREMITY (Hurt arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. Treatment information was not reported.   Reporter did not allow further contact
Moderna Covid 19 vaccine given to patient under 18 as approved for EAU for 18 and over. Soreness in arm, No other adverse events known/reported by patient at this time.
First dose: no symptoms. Second dose three weeks later: low fever, nausea, chills, body aches, fatigue and headache. All mild. Caused discomfort but still able to work. Second dose also caused injection site pain beyond normal duration, redness and swelling. Also mild as of two days post-vaccination.
Information has been received from a physician concerning a child patient who in approximately 1999 was vaccinated with a dose of varicella virus vaccine live. On 11Jul2003, the reporter stated that the pt now has full blown chickenpox. Unspecified medical attention was sought and the pt's parent spoke with the reporting physician. At the time of the report the pt was not recovered. a product quality complaint was not involved. Additional information has been requested.
At 12:35am, mom finds infant in crib starring up on ceiling, temp 103 deg. F., not responding normally, "awake but out of it." This episode lasted 5-15 mins during which called physician and was instructed to put baby in bath and child began crying. Mom had omitted pm dose of Motrin. Gave Tylenol and Motrin as directed. At 1am, the pt responding normally, temp went down. At 7am, slept with parents. Temp remains off and on with use of Tylenol. At 1pm the next day, the pt was seen by a physician and he felt that the child had a "febrile seizure."
Redness, swelling, pain left arm inj. site. Fever of 103 degrees since 2/3/12 - pt. is still hospitalized.
On 09/21/2023, Patient received co-administered vaccination flu and covid at 1:12pm and left store at 1:15pm.  She reentered store at 1:20pm and reported experiencing reaction to vaccines; tightness in chest, difficulty breathing and pains spreading across chest from left to right.  She was asked if she needed medical assistance in which she stated she did. 911 was called and patient was transported from store to hospital via ambulance at 1:44pm.
About an hour or so later after receiving the 1st dose of Pfizer COVID-19 vaccine, I started having muffled hearing or clogged ears like when you come down from a plane ride and your ears have not ?popped yet? or when you drive up a mountain or high altitude, and then immediately, ringing in the ears(both ears) clogged and ringing. Took an ibuprofen and it got better by the time I went to sleep but it is still a bit muffled or clogged, especially on my left ear.  Titinnus?
Itching; looked at the back and have a rash; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EpT534) via an unspecified route of administration in the left arm on 01Apr2021 at 08:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, hypertension, cholesterol high and back problems. The patient took unspecified concomitant medications. The patient did not have any known allergy to any medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 12:30, the patient noticed that she was itching and when looked at her back she had a rash. On 02Apr2021, the itching was more than the previous day. The events did not result in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive any treatment for the events itching and rash. The clinical outcomes of the events itching and rash was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
pt recvd vax;devel a localized myalgia at inject site; pt presented w/ low grade fever;
Pt received the COVID vaccine 03/15/2021 at store. Per patient states that since then she has been having issues with blood pressure running high. Patient is on blood pressure medication but was stable and under control prior to vaccine .
I came home from a girl's trip, I felt like I had a cold, but I had diarrhea, I never had a cough. I took a home COVID-19 test that came back positive. I called the health department; we discussed my symptoms and medications. They said I needs to take the antiviral Lagevrio, that I was able to start taking that day. Every day I was feeling better.
My face got red and itchy about 28 hours after the injection and eventually got raised and really red around one of my sinuses (on the left side, same as the side I got the injection.) it?s 3 days later And I?m still a bit red and itchy but not as bad.
Patient was given Pfizer Covid vaccine in left arm and immediately said she could feel the injection being injected and that it was painful. She then complained of pain around injection site, followed by pain in the neck. She was evaluated by 2 pharmacist and given a cold compress and informed to stay to be monitored for at least 30 minutes. After about 10 minutes she said the pain was no longer in her neck but had traveled to the left side of her back. She showed no other symptoms during the event besides injection site pain, followed by neck pain then back pain. She stayed for about 40 minutes before she said she was feeling fine and left.
Patient reported "tongue feels fat" at 1839, states she had same symptoms occurred with first pfizer vaccine. at this time pt denies shortness of breath. she denies any other symptom at this time. Zyrtec 10ml oral given, pt able to swallow w/o any complications. vitals signs taken, BP: 167/83, hr: 78, O2 sat: 98%, RR: 16. After 30 minutes of additional observation pt stated tongue swelling was no longer present. patient was discharged home without any complications.
Poison ivy; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (Poison ivy), MYALGIA (body aches) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced MYALGIA (body aches) and CHILLS (chills). On 04-Sep-2021, the patient experienced DERMATITIS CONTACT (Poison ivy). The patient was treated with PREDNISONE ongoing since an unknown date for Poison ivy rash, at an unspecified dose and frequency. On 19-Aug-2021, MYALGIA (body aches) and CHILLS (chills) had resolved. At the time of the report, DERMATITIS CONTACT (Poison ivy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Aug-2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. The patient came in contact with poison Ivy on 04-Sep-2021 and was treated with prednisone. She called to find out how the prednisone might affect her second dose of Moderna Covid-19 vaccine that is due later in September.   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Significant follow-up added.  Added event of poison ivy.
Patient received second dose vaccine outside the recommended 6-week interval. First dose administered 3/31/21, second dose administered 7/11/21 (102 days later).
FEELING TERRIBLE; FLU-LIKE SYMPTOMS; BODY ACHES AND SORENESS; LETHARGY; DIFFICULTY CONCENTRATING; CHILLS; TIRED; This spontaneous report received from a consumer concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the subject experienced feeling terrible. On 11-APR-2021, the subject experienced flu-like symptoms. On 11-APR-2021, the subject experienced body aches and soreness. On 11-APR-2021, the subject experienced lethargy. On 11-APR-2021, the subject experienced difficulty concentrating. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling terrible, flu-like symptoms, body aches and soreness, lethargy, difficulty concentrating, chills, and tired. This report was non-serious.
Hot tender, really sore. Hands/knees/joints hurt. Took BENADRYL OTC - symptoms resolved.
Systemic: Bilateral shoulder join soreness.-Medium, Systemic: Joint Pain-Medium
Mild symptoms the first two days after the shot such as headache, sore arm. Twelve days after the shot I noticed a large red patch at the injection site that was very red, hot and itchy.
Shaking of both arms  2/5/21  Felt mild  SOB after second dose
Low grade fever; she can't function or do anything; something that eventually is going to kill her. It is overwhelming, she should have never done this, she doesn't wanna die; she is getting sicker; feels like somebody drugged her with something that eventually is going to kill her/feels like she is drugged or that something is invading her body, she can't function or do anything; This is a spontaneous report from a contactable consumer (patient). A 60-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 23Mar2021 as dose 1, single for covid-19 immunization. Medical history included Seasonal allergy (stated that she was normally a healthy person, she had inhalant and seasonal allergies), chemical sensitivity and hypoglycemia. Concomitant medications were not reported. On an unspecified date in 2021, the patient experienced that she was getting sicker, feels like somebody drugged her with something that eventually was going to kill her/feels like she was drugged or that something was invading her body, she can't function or do anything and on 25Mar2021, the patient experienced low grade fever. It was reported that, patient got the first dose of Pfizer's COVID-19 vaccine on Tuesday 23Mar2021 afternoon, this was awful. She got sick, lived alone, her body was not accepting the vaccine and she was getting sicker. She said that the first day she was energized which was Wednesday, then Thursday there were symptoms, and she went to work and had a low-grade fever, so she couldn't stay at work. She says Friday she felt the same, just a rush of all symptoms that are not getting better. She says now it was Wednesday morning and it was unbelievable, it had been 7 days, now was the 8th day, she could do anything in the morning, felt like she was drugged her with something that eventually was going to kill her or that something was invading her body, she can't function or do anything. It was overwhelming, she should have never done this, she doesn't want to die. She says she was normally a healthy person, she had inhalant and seasonal allergies and some chemical sensitivities and hypoglycemia. She says that she doesn't know how to reverse this reaction and lives alone, and she doesn't know if she should call 911. She says she needs to find out how to feel better, and needs to speak to someone, and does not wish to complete a report. On 25Mar2021, the patient lab tests included fever: low grade. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
received Pfizer vaccines on 12/18/20, 1/8/21. Tested positive for COVID by PCR on 4/21/21.
3 months after shot 3 (first booster) had first stroke on 22-Feb-2022. RIght side Ballance area damaged and left side face numbness. recovered in about 2 weeks. Numbness persisted. Home care help needed  shot 4 (second booster) Pfizer lot FP4554 mRNA Gray cap,  0n 20-July 2022 , 3 months later 12-Oct-2022 had second stroke/(TIA). Same area right side brain,  this time left arm and face numbness. recovered 2 days  Shot 5 (third booster and last) Pfizer lot GH9702 mRNA Bivalent Booster 30mcg on 17-Oct-2022, 3rd stroke 6-Nov-2022, hosptial 5 days, then 6 days inpatient rehab left arm not working, then about 4 weeks in home rehab.
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Visual Changes/Disturbances-Severe
OVERNIGHT FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced overnight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of overnight fever was not reported. This report was non-serious.
ACCORDING TO DAD, HE GOT THE VACCINE ON 4/28/21. ON MAY 11  HE WAS COMPLAINING OF N/V, LATER HEADACHE AND ALTERED VISION, ENCEPHALOPATHY, CARDIAC  ARREST AND  DEATH.... AFTER MULTIPLE LOCAL ER VISITS. HE NEVER HAD FEVER. I WAS CALLED ON HIS CASE DUE TO CONCERN FOR CNS INFECTION. HE WAS ADMITTED ON 5/18 AND DIED ON 5/20 THIS  MAY OR MAY NOT BE RELATED TO THE COVID VACCINE, BUT IT IS IMPORTANT IT IS REPORTED JUST INCASE IT IS AND MAY HELP SOMEONE.
Approx 1 day p/receiving a dose of Influenva, pt devel severe pain in arm of inject radiating to shoulder, neck, & back; rxn was treated w/Vicodin & Naprosyn, sx resolved in 7 to 10 days;
Facial rash/Rash; lip and eye swelling; lip and eye swelling; hives; itching arms stomach and hand palms; headache; chills; fatigue; arm pain at injection site; This is a spontaneous report from a contactable consumer (Patient). A 66-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN8200), dose 2 via an unspecified route of administration, administered in Arm Left on 14Feb2021(Age at vaccination: 66 years) as dose 2, 0.3 ml single for covid-19 immunisation. Medical history included Osteoporosis, elevated cholesterol, panic attacks. Patient had known allergies of Environmental, barley, rye, prescribed narcotic medicine.  Concomitant medications included Alendronate Sodium 70 mg; vitamin b complex (VITAMIN B); Zinc; colecalciferol (VITAMIN D [COLECALCIFEROL]); vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); Calcium. Historical vaccine included bnt162b2 (COMIRNATY) 0.3 ml as dose 1 received on 24Feb2021 at 9AM in left arm with lot number EL3247 for covid-19 immunisation. Patient did not receive other vaccines in 4 weeks. The patient experienced facial rash/ rash, lip and eye swelling, hives, itching arms stomach and hand palms, headache, chills, fatigue, arm pain at injection site on 26Feb2021. Facial rash/rash, lip and eye swelling/hives/itching arms, stomach and hand palms. All occurred approximately 2 weeks after the second dose and was currently ongoing. Other reactions were headache, chills, fatigue, arm pain at injection site which went away within 48 hours after the injection. Took over the counter allergy medicine Benedryl. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination.  The outcome of the events headache, chills, fatigue, arm pain at injection site was recovered on 28Feb2021. The outcome of the rest of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Mother presents to office with c/o rash noted this a.m. on child. Initially began on lips now spreading to arms, chest?, lower lip. Afebrile, denies pain or pruritus.
LEFT ARM IS STILL WARM TO TOUCH LEFT ARM HAS A INTERNAL ITCH   LEFT IS STILL SWOLLEN  CHEST PAINS (MILD)
delayed cutaneous hypersensitivity - softball-sized area of redness & swelling, itching at the site.
woke up with nausea; woke up with malaise; experienced chills; This case was reported by a consumer via call center representative and described the occurrence of chills in a 87-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on an unknown date and experienced arm soreness, refer case US2020AMR010349).   On 16th January 2020, the patient received the 2nd dose of Shingrix. On 16th January 2020, less than a day after receiving Shingrix, the patient experienced chills. On 17th January 2020, the patient experienced nausea and malaise. On an unknown date, the outcome of the chills was resolved with sequelae and the outcome of the nausea and malaise were recovering/resolving.   It was unknown if the reporter considered the chills, nausea and malaise to be related to Shingrix.  Additional details were received as follows: The reporter stated that the patient experienced chills that caused her to fall out of bed. The patient was assessed at home and helped back to bed. The patient also had nausea and malaise after vaccination. The reporter consented to follow up.
No adverse events, this is to report a medication error. Patient was to receive MENACTRA vaccine and was given PEDVAXHIB in error. No adverse reaction reported.
shingles; Post herpetic neuralgia; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included TETANUS TOXOID (TETANUS VACCINE) for prophylaxis.   Concurrent medical conditions included post herpetic neuralgia and sinus infection.   On 12th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml and TETANUS VACCINE. On 19th September 2019, 99 days after receiving Shingrix, the patient experienced shingles and post herpetic neuralgia. The patient was treated with acyclovir and steroids nos (Steroids). On an unknown date, the outcome of the shingles and post herpetic neuralgia were unknown.   It was unknown if the reporter considered the shingles and post herpetic neuralgia to be related to Shingrix.  Additional details were provided as follows: The reporter stated that she received her dose 1st of Shingrix vaccine with a tetanus vaccine and while being treated for a sinus infection. She stated that she was treated for the sinus infection with antibiotics and then developed a yeast infection. on 19th September 2019, she developed shingles and was treated with acyclovir and steroids. She stated that she still has post herpatic neuralgia. The reporter did not consent to follow-up. The reporter did not have vaccine information for this adverse event (AE).
syncope; blood pressures issues; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (syncope) and BLOOD PRESSURE ABNORMAL (blood pressures issues) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (syncope) (seriousness criteria hospitalization and medically significant) and BLOOD PRESSURE ABNORMAL (blood pressures issues) (seriousness criterion hospitalization). At the time of the report, SYNCOPE (syncope) and BLOOD PRESSURE ABNORMAL (blood pressures issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Patient did not get the 2nd dose of the Moderna vaccine because she experienced blood pressure issues that resulted in Hospitalization two separate occasions; once on the Sunday after the vaccine and then the following Wednesday after the vaccine. Caller states, "I feel very afraid of the 2nd shot. I was afraid to get the 2nd shot because of the bad experience with the 1st one. She passed out 2 times, son had to call 911."  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Case upgraded case to serious. Added event of syncope; hospitalization.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
High fever, rash (maybe pox), diarrhea, loss of appetite, hives, lethargy.
breakthrough seizure 8 days after; possibly unrelated would like to inform; hadn't had one for 4 years prior to that